三星医疗：子公司签订3.41亿元海外经营合同

Core Viewpoint - Samsung Medical's subsidiary has secured a significant overseas contract worth approximately 341 million RMB, which represents a notable portion of the company's projected revenue for 2024 [1] Group 1 - Samsung Medical announced that its wholly-owned subsidiary, Nansen Instrumentos de Precisão Ltda, won a procurement framework contract for transformers in Brazil [1] - The total contract amount is 26,329.80 million Brazilian Reais, equivalent to about 341 million RMB [1] - This contract accounts for 2.33% of the company's audited operating revenue for the fiscal year 2024 [1]